CP-481,715, a Potent and Selective CCR1 Antagonist with Potential Therapeutic Implications for Inflammatory Diseases
Open Access
- 1 October 2003
- journal article
- Published by Elsevier
- Vol. 278 (42) , 40473-40480
- https://doi.org/10.1074/jbc.m306875200
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Chemokine receptors: multifaceted therapeutic targetsNature Reviews Immunology, 2002
- Control of leukocyte rolling velocity in TNF-α–induced inflammation by LFA-1 and Mac-1Blood, 2002
- Identification of the Binding Site for a Novel Class of CCR2b Chemokine Receptor AntagonistsPublished by Elsevier ,2000
- In vitro migration of mononuclear cells towards synovial fluid and plasma from rheumatoid arthritis patients correlates to RANTES synovial fluid levels and to clinical pain parametersScandinavian Journal of Rheumatology, 2000
- Polyclonal antibody directed against human RANTES ameliorates disease in the Lewis rat adjuvant-induced arthritis model.Journal of Clinical Investigation, 1998
- Agonist-independent Activation of Gz by the 5-Hydroxytryptamine1A Receptor Co-expressed in Spodoptera frugiperda CellsPublished by Elsevier ,1997
- Chemokine expression in rheumatoid arthritis (RA): evidence of RANTES and macrophage inflammatory protein (MIP)-1β production by synovial T cellsClinical and Experimental Immunology, 1995
- Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis.Journal of Clinical Investigation, 1995
- Actions of the chemotactic cytokines MCP‐1, MCP‐2, MCP‐3, RANTES, MIP‐1α and MIP‐1β on human monocytesEuropean Journal of Immunology, 1995
- Macrophage inflammatory protein-1 alpha. A novel chemotactic cytokine for macrophages in rheumatoid arthritis.Journal of Clinical Investigation, 1994